BECN1 and breast cancer: Certain factors interact with beclin-1 to inhibit its activity and thereby promote tumorigenesis through inhibition of autophagy, such as human epidermal growth factor receptor 2 (HER2), which was found to bind beclin-1 and prevent formation of VPS34 complex I, inducing tumorigenesis in breast cancer cells [17].